← Leaderboards
Katherine E Warren
Basic Sciences
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Basic Sciences
Same institution · by research overlap
Others in their field
Top investigators on “Child”
- Barbara Driver · Westat, Inc.$244,454,458
- Sharon A Nachman · Johns Hopkins University$212,395,175
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$195,214,889
- George R Seage · Abt Associates, Inc.$189,009,744
- Carol Nesel · Westat$188,148,170
- Elizabeth A Thom · George Washington University$170,579,744
Research focus
ChildTumorCentral Nervous System NeoplasmsGliomaChildhoodDiffuseDosePontine StructureAdultBrain Stem GliomaToxic EffectRadiation TherapyResponseRadiationOperative Surgical ProceduresCytotoxicDiagnosisChildhood Central Nervous System NeoplasmChemotherapeutic AgentClinical TrialsEnrollmentCellsLocationImage
Grant awards (145)
Preclinical evaluation of novel therapeutics for CNS tumor therapy$487,429
ZIA · FY2019 · CA · contact PI
The DIPG All-In Initiative$266,926
ZIA · FY2019 · CA · contact PI
Investigating Pediatric CNS tumor biology$139,266
ZIA · FY2019 · CA · contact PI
Early Clinical Trials for Children with CNS Tumors$116,055
ZIA · FY2019 · CA · contact PI
Noninvasive Evaluation of Pediatric CNS Tumors-RAPNO$58,027
ZIA · FY2019 · CA · contact PI
Exploratory Study of Biologic and Pathophysiologic Effects of Radiation Therapy$46,422
ZIA · FY2019 · CA · contact PI
Phase I Trial of Radiation and Lenalidomide in Pediatric Malignant Glioma$23,211
ZIA · FY2019 · CA · contact PI
The International DIPG Registry$11,605
ZIA · FY2019 · CA · contact PI
Phase II Trial of PEG-Intron in Children with Diffuse Pontine Gliomas$11,605
ZIA · FY2019 · CA · contact PI
Preclinical evaluation of novel therapeutics for CNS tumor therapy$569,613
ZIA · FY2018 · CA · contact PI
The DIPG All-In Initiative$311,931
ZIA · FY2018 · CA · contact PI
Investigating Pediatric CNS tumor biology$162,747
ZIA · FY2018 · CA · contact PI
Early Clinical Trials for Children with CNS Tumors$135,623
ZIA · FY2018 · CA · contact PI
Noninvasive Evaluation of Pediatric CNS TumorsRAPNO$67,811
ZIA · FY2018 · CA · contact PI
Exploratory Study of Biologic and Pathophysiologic Effects of Radiation Therapy$54,249
ZIA · FY2018 · CA · contact PI
Phase I Trial of Radiation and Lenalidomide in Pediatric Malignant Glioma$27,124
ZIA · FY2018 · CA · contact PI
Phase II Trial of PEG-Intron in Children with Diffuse Pontine Gliomas$13,562
ZIA · FY2018 · CA · contact PI
The International DIPG Registry$13,562
ZIA · FY2018 · CA · contact PI
Preclinical evaluation of novel therapeutics for CNS tumor therapy$559,730
ZIA · FY2017 · CA · contact PI
Early Clinical Trials for Children with CNS Tumors$399,808
ZIA · FY2017 · CA · contact PI
Investigating Pediatric CNS tumor biology$159,923
ZIA · FY2017 · CA · contact PI
Phase I Trial of Radiation and Lenalidomide in Pediatric Malignant Glioma$66,634
ZIA · FY2017 · CA · contact PI
Noninvasive Evaluation of Pediatric CNS Tumors$66,634
ZIA · FY2017 · CA · contact PI
Exploratory Study of Biologic and Pathophysiologic Effects of Radiation Therapy$53,307
ZIA · FY2017 · CA · contact PI
Establishment of an International DIPG Registry$13,327
ZIA · FY2017 · CA · contact PI
Phase II Trial of PEG-Intron in Children with Diffuse Pontine Gliomas$13,327
ZIA · FY2017 · CA · contact PI
Preclinical evaluation of novel therapeutics for CNS tumor therapy$506,281
ZIA · FY2016 · CA · contact PI
Early Clinical Trials for Children with CNS Tumors$399,695
ZIA · FY2016 · CA · contact PI
Exploratory Study of Biologic and Pathophysiologic Effects of Radiation Therapy$133,232
ZIA · FY2016 · CA · contact PI
Investigating Pediatric CNS tumor biology$133,232
ZIA · FY2016 · CA · contact PI
Noninvasive Evaluation of Pediatric CNS Tumors$66,615
ZIA · FY2016 · CA · contact PI
Phase I Trial of Radiation and Lenalidomide in Pediatric Malignant Glioma$66,615
ZIA · FY2016 · CA · contact PI
Phase II Trial of PEG-Intron in Children with Diffuse Pontine Gliomas$13,322
ZIA · FY2016 · CA · contact PI
Establishment of an International DIPG Registry$13,322
ZIA · FY2016 · CA · contact PI
Early Clinical Trials for Children with CNS Tumors$425,860
ZIA · FY2015 · CA · contact PI
Preclinical evaluation of novel therapeutics for CNS tumor therapy$425,860
ZIA · FY2015 · CA · contact PI
Exploratory Study of Biologic and Pathophysiologic Effects of Radiation Therapy$141,954
ZIA · FY2015 · CA · contact PI
Investigating Pediatric CNS tumor biology$141,954
ZIA · FY2015 · CA · contact PI
Noninvasive Evaluation of Pediatric CNS Tumors$141,954
ZIA · FY2015 · CA · contact PI
Phase I Trial of Radiation and Lenalidomide in Pediatric Malignant Glioma$70,976
ZIA · FY2015 · CA · contact PI
Convection enhanced delivery of agents into the brainstem of glioma patients$42,586
ZIA · FY2015 · CA · contact PI
Phase II Trial of PEG-Intron in Children with Diffuse Pontine Gliomas$14,195
ZIA · FY2015 · CA · contact PI
Establishment of an International DIPG Registry$14,195
ZIA · FY2015 · CA · contact PI
Preclinical evaluation of novel therapeutics for CNS tumor therapy$353,117
ZIA · FY2014 · CA · contact PI
Early Clinical Trials for Children with CNS Tumors$353,117
ZIA · FY2014 · CA · contact PI
Noninvasive Evaluation of Pediatric CNS Tumors$117,706
ZIA · FY2014 · CA · contact PI
Exploratory Study of Biologic and Pathophysiologic Effects of Radiation Therapy$117,706
ZIA · FY2014 · CA · contact PI
Investigating Pediatric CNS tumor biology$117,706
ZIA · FY2014 · CA · contact PI
Phase I Trial of Radiation and Lenalidomide in Pediatric Malignant Glioma$58,853
ZIA · FY2014 · CA · contact PI
Convection enhanced delivery of agents into the brainstem of glioma patients$35,311
ZIA · FY2014 · CA · contact PI
Establishment of an International DIPG Registry$11,770
ZIA · FY2014 · CA · contact PI
Phase II Trial of PEG-Intron in Children with Diffuse Pontine Gliomas$11,770
ZIA · FY2014 · CA · contact PI
Preclinical development of new therapeutics for children with CNS Tumors$205,422
ZIA · FY2013 · CA · contact PI
Clinical Development of New Agents for Children with CNS Tumors$195,152
ZIA · FY2013 · CA · contact PI
Noninvasive Evaluation of Pediatric CNS Tumors$102,712
ZIA · FY2013 · CA · contact PI
Investigating the biology of pediatric gliomas$102,712
ZIA · FY2013 · CA · contact PI
Exploratory Study of Biologic and Pathophysiologic Effects of Radiation Therapy$102,712
ZIA · FY2013 · CA · contact PI
Establishment of an International DIPG Registry$51,356
ZIA · FY2013 · CA · contact PI
Ph I Radiation and Lenalidomide in pediatric malignant glioma$51,356
ZIA · FY2013 · CA · contact PI
Diffuse Intrinsic Pontine Glioma Genomic Study$51,356
ZIA · FY2013 · CA · contact PI
Differential Gene Expression and Targeting of Gliomas Using Radiation$51,356
ZIA · FY2013 · CA · contact PI
Convection enhanced delivery of agents into the brainstem of glioma patients$51,356
ZIA · FY2013 · CA · contact PI
Phase II Trial of PEG-Intron in Children with Diffuse Pontine Gliomas$51,356
ZIA · FY2013 · CA · contact PI
Imaging as a Biomarker for Diffuse Intrinsic Brainstem Gliomas$10,272
ZIA · FY2013 · CA · contact PI
Preclinical development of new therapeutics for children with CNS Tumors$237,394
ZIA · FY2012 · CA · contact PI
Noninvasive Evaluation of Pediatric CNS Tumors$118,698
ZIA · FY2012 · CA · contact PI
Investigation of Immune Status and Function in Children with CNS Tumors$118,698
ZIA · FY2012 · CA · contact PI
Clinical Development of New Agents for Children with CNS Tumors$118,698
ZIA · FY2012 · CA · contact PI
Imaging as a Biomarker for Diffuse Intrinsic Brainstem Gliomas$118,698
ZIA · FY2012 · CA · contact PI
Convection enhanced delivery of agents into the brainstem of glioma patients$59,349
ZIA · FY2012 · CA · contact PI
Phase II Trial of PEG-Intron in Children with Diffuse Pontine Gliomas$59,349
ZIA · FY2012 · CA · contact PI
Phase II Trial of O6-Benzylguanine and Temozolomide in Pediatric Patients with H$59,349
ZIA · FY2012 · CA · contact PI
Exploratory Study of Biologic and Pathophysiologic Effects of Radiation Therapy$59,349
ZIA · FY2012 · CA · contact PI
Differential Gene Expression and Targeting of Gliomas Using Radiation$59,349
ZIA · FY2012 · CA · contact PI
Diffuse Intrinsic Pontine Glioma Genomic Study$59,349
ZIA · FY2012 · CA · contact PI
Ph I Radiation and Lenalidomide in pediatric malignant glioma$59,349
ZIA · FY2012 · CA · contact PI
Establishment of an International DIPG Registry$59,349
ZIA · FY2012 · CA · contact PI
Preclinical development of new therapeutics for children with CNS Tumors$374,038
ZIA · FY2011 · CA · contact PI
An Exploratory Study of Biologic and Pathophysiologic Efects of Radiation Therap$187,019
ZIA · FY2011 · CA · contact PI
Noninvasive Evaluation of Pediatric CNS Tumors$124,679
ZIA · FY2011 · CA · contact PI
Imaging as a Biomarker for Diffuse Intrinsic Brainstem Gliomas$124,679
ZIA · FY2011 · CA · contact PI
Diffuse Intrinsic Pontine Glioma Genomic Study$62,340
ZIA · FY2011 · CA · contact PI
Differential Gene Expression and Targeting of Gliomas Using Radiation$62,340
ZIA · FY2011 · CA · contact PI
Convection enhanced delivery of agents into the brainstem of patients with diff$62,340
ZIA · FY2011 · CA · contact PI
Phase II Trial of O6-Benzylguanine and Temozolomide in Pediatric Patients with H$62,340
ZIA · FY2011 · CA · contact PI
Ph I Radiation and Lenalidomide in pediatric malignant glioma$62,340
ZIA · FY2011 · CA · contact PI
Phase II Trial of PEG-Intron in Children with Diffuse Pontine Gliomas$62,340
ZIA · FY2011 · CA · contact PI
Establishment of an International DIPG Registry$62,340
ZIA · FY2011 · CA · contact PI
Preclinical development of new therapeutics for children with CNS Tumors$355,883
ZIA · FY2010 · CA · contact PI
An Exploratory Study of Biologic and Pathophysiologic Efects of Radiation Therap$355,883
ZIA · FY2010 · CA · contact PI
Imaging as a Biomarker for Diffuse Intrinsic Brainstem Gliomas$177,942
ZIA · FY2010 · CA · contact PI
Noninvasive Evaluation of Pediatric CNS Tumors$177,942
ZIA · FY2010 · CA · contact PI
Differential Gene Expression and Targeting of Gliomas Using Radiation$177,942
ZIA · FY2010 · CA · contact PI
A Phase I Trial of CC-5013 (lenalidomide) in Pediatric Patients with Recurrent o$88,970
ZIA · FY2010 · CA · contact PI
Ph I Radiation and Lenalidomide in pediatric malignant glioma$88,970
ZIA · FY2010 · CA · contact PI
Diffuse Intrinsic Pontine Glioma Genomic Study$88,970
ZIA · FY2010 · CA · contact PI
Convection enhanced delivery of agents into the brainstem of patients with diff$88,970
ZIA · FY2010 · CA · contact PI
Phase II Trial of O6-Benzylguanine and Temozolomide in Pediatric Patients with H$88,970
ZIA · FY2010 · CA · contact PI
Phase II Trial of PEG-Intron in Children with Diffuse Pontine Gliomas$88,970
ZIA · FY2010 · CA · contact PI
Imaging as a Biomarker for Diffuse Intrinsic Brainstem Gliomas$198,668
ZIA · FY2009 · CA · contact PI
An Exploratory Study of Biologic and Pathophysiologic Efects of Radiation Therap$132,444
ZIA · FY2009 · CA · contact PI
Phase II Trial of PEG-Intron in Children with Diffuse Pontine Gliomas$99,333
ZIA · FY2009 · CA · contact PI
Convection enhanced delivery of agents into the brainstem of patients with diff$66,222
ZIA · FY2009 · CA · contact PI
Differential Gene Expression and Targeting of Gliomas Using Radiation$66,222
ZIA · FY2009 · CA · contact PI
Phase II Trial of O6-Benzylguanine and Temozolomide in Pediatric Patients with$33,111
ZIA · FY2009 · CA · contact PI
Diffuse Intrinsic Pontine Glioma Genomic Study$33,111
ZIA · FY2009 · CA · contact PI
A Phase I Trial of CC-5013 (lenalidomide) in Pediatric Patients with Recurrent o$33,111
ZIA · FY2009 · CA · contact PI
An Exploratory Study of Biologic and Pathophysiologic Efects of Radiation Therap$123,314
Z01 · FY2008 · CA · contact PI
Differential Gene Expression and Targeting of Gliomas Using Radiation$123,314
Z01 · FY2008 · CA · contact PI
Imaging as a Biomarker for Diffuse Intrinsic Brainstem Gliomas$123,314
Z01 · FY2008 · CA · contact PI
Phase II Trial of PEG-Intron in Children with Diffuse Pontine Gliomas$92,486
Z01 · FY2008 · CA · contact PI
Convection enhanced delivery of agents into the brainstem of patients with diff$61,657
Z01 · FY2008 · CA · contact PI
Diffuse Intrinsic Pontine Glioma Genomic Study$30,829
Z01 · FY2008 · CA · contact PI
Phase II Trial of O6-Benzylguanine and Temozolomide in Pediatric Patients with$30,829
Z01 · FY2008 · CA · contact PI
A Phase I Trial of CC-5013 (lenalidomide) in Pediatric Patients with Recurrent o$30,829
Z01 · FY2008 · CA · contact PI
Phase II Trial of O6-Benzylguanine and Temozolomide in Pediatric Patients with H$191,616
Z01 · FY2007 · CA · contact PI
1H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients who$164,437
Z01 · FY2007 · CA · contact PI
Convection enhanced delivery of agents into the brainstem of patients with diff$164,437
Z01 · FY2007 · CA · contact PI
An Exploratory Study of Biologic and Pathophysiologic Efects of Radiation Therap$164,437
Z01 · FY2007 · CA · contact PI
Imaging characteristics of Diffuse Pontine Gliomas after Radiation Therapy$164,437
Z01 · FY2007 · CA · contact PI
Evaluation of the Natural History of Patients with Tumors of the Central Nervous$164,437
Z01 · FY2007 · CA · contact PI
A Comparative Study of Pediatric CNS Tumor Activity as Assessed by18F-- FDG PET$164,437
Z01 · FY2007 · CA · contact PI
Phase II Trial of PEG-Intron in Children with Diffuse Pontine Gliomas$164,437
Z01 · FY2007 · CA · contact PI
A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatri$164,437
Z01 · FY2007 · CA · contact PI
A Phase I Trial of CC-5013 (lenalidomide) in Pediatric Patients with Recurrent o$137,257
Z01 · FY2007 · CA · contact PI
Phase I Trial and Pharmacokinetic Study of Temozolomide and O6-Benzylguanine in$110,077
Z01 · FY2007 · CA · contact PI
An Exploratory Study of Biologic and Pathophysiologic Ef$0
Z01 · FY2006 · BC · contact PI
A Pilot Study of 1H-Nuclear Magnetic Resonance Spectrosc$0
Z01 · FY2006 · BC · contact PI
A Phase I Trial of CC-5013 (lenalidomide) in Pediatric P$0
Z01 · FY2006 · BC · contact PI
A Comparative Study of Pediatric CNS Tumor Activity as A$0
Z01 · FY2006 · BC · contact PI
1H-Nuclear Magnetic Resonance Spectroscopic Imaging of t$0
Z01 · FY2006 · BC · contact PI
Phase II Trial of PEG-Intron in Children with Diffuse Po$0
Z01 · FY2006 · BC · contact PI
Phase I Trial and Pharmacokinetic Study of Temozolomide$0
Z01 · FY2006 · BC · contact PI
Evaluation of the Natural History of Patients with Tumor$0
Z01 · FY2006 · BC · contact PI
Phase II Trial of O6-Benzylguanine and Temozolomide in P$0
Z01 · FY2006 · BC · contact PI
Imaging characteristics of Diffuse Pontine Gliomas after$0
Z01 · FY2006 · BC · contact PI
Phase II Trial of PEG-Intron in Children with Diffuse Po$0
Z01 · FY2005 · BC
A Comparative Study of Pediatric CNS Tumor Activity as A$0
Z01 · FY2005 · BC
Phase II Trial of O6-Benzylguanine and Temozolomide in P$0
Z01 · FY2005 · BC
Imaging characteristics of Diffuse Pontine Gliomas after$0
Z01 · FY2005 · BC
Evaluation of the Natural History of Patients with Tumor$0
Z01 · FY2005 · BC
A Phase I Trial of CC-5013 (lenalidomide) in Pediatric P$0
Z01 · FY2005 · BC
A Pilot Study of 1H-Nuclear Magnetic Resonance Spectrosc$0
Z01 · FY2005 · BC
Phase I Trial and Pharmacokinetic Study of Temozolomide$0
Z01 · FY2005 · BC
1H-Nuclear Magnetic Resonance Spectroscopic Imaging of t$0
Z01 · FY2005 · BC